Amy Calistri
Stock of the Month
Stephen Leeb
Income Performance Report
Roger Conrad
The Utility Forecaster
Paul McWilliams
Next Inning

Insiders target Zoran (ZRAN)


Bookmark and Share

 Recent corporate insider buying at tech company Zoran (NASDAQ: ZRAN) has attracted the attention of Paul McWilliams. Here's the "inside story" from his Next Inning service.

For the most part, there's not been that much activity in the overall technology sector. However, I noticed that the CEO at Zoran had stepped up to the plate recently with a $98K buy.

"And, when looking more closely, I noticed that two directors have also been recent buyers, one for $43K and the other for $68K.

Advertisement
Banner

"While the aggregate dollar amount here isn't huge, for a company the size of ZRAN and when considering there were three different buyers, it shows at the very least confidence.

" In addition to this, CEO Levy Gerzberg has shown good timing in his insider activity going back to 2005. In looking at his record we can see that sells were made in 2005, 2006 and 2007 at prices ranging from $20.19 to $27.31.

"Between these, a large buy was executed in 2006 at $12.36. More recently we saw him as a buyer in 2008 at $8.28 and $8.30 and then again last week at $9.80.

"With comfortably more than $7 in balance sheet value, I think the downside for ZRAN is reasonably cushioned.

"Zoran is involved in digital entertainment and digital imaging products. I think ZRAN's exposure to the flat panel TV market via its Supra TV processor is being underestimated by Wall Street.

"Therefore, I think there is some reasonable room for a near-term upside to the rather dismal expectations listed from the 11 covering analysts.

"Based on this thinking and the vote of confidence implied by three insider buyers, I think there is room to speculate here for a price in the mid-teens during the coming year."


Banner
News Flash

Linkedin: Professional profits
by Leo Fasciocco, editor Ticker Tape Digest

Online professional network operator Linkedin (LNKD) recently moved above its technical breakout point of $108.53. We now target a move to $138.


Read more...

 

Tap in to water stocks
by Doug Fabian, editor Making Money Alert

As we prepare for the summer heat, water presents a significant investment opportunity -- especially as states such as California and Texas face droughts. The PowerShares Water Resource ETF (PHO) presents one way to invest in water's untapped potential.


Read more...


   

Pax World: High yield exception
by Amy Calistri, editor The Daily Paycheck

I generally prefer closed-end or exchange-traded funds because the fees tend to be lower. But I made a special case for Pax World High Yield Bond (PAXHX); this high-yield bond fund is my only open-ended mutual fund holding.


Read more...

 

Amgen: Biotech DRIP
by Chuck Carlson, editor DRIP Investor

Amgen (AMGN) is one of the oldest and largest players in the biotechnology area. It pioneered the development of products based on advances in recombinant DNA and molecular biology, launching the biotechnology industry’s first blockbuster medicines.


Read more...

 

Fidelity fund expert looks to Japan
by Jim Lowell, editor Fidelity Investor

In my May Marketwatch investment strategy column I noted, “Set against the backdrop of having already been thrown out with the Eurozone’s bathwater, I like Japan’s marketplace overall and, more specifically, their small cap marketplace which caters to domestic counter traffic.”


Read more...

 

MOO: Market Vectors Agribusiness
by Doug Fabian, editor Making Money Alert

Everyone needs food to survive, so wouldn't it be great to make money from it? We can. The global agriculture business provides a fairly stable investment with growth potential. In particular, I am looking at Market Vectors Agribusiness ETF (MOO).


Read more...

 

Celgene: Selloff creates opportunity
by J. Royden Ward, editor Cabot Benjamin Graham Value Letter

Celgene (CELG) develops and assists in the marketing of drugs to treat cancer and infl ammatory diseases. It acquired several companies recently, which will expand its product line and add promising products in various stages of development.


Read more...

 

Senior housing reits for income
by Brian Hicks, editor Wealth Advisory

Omega Healthcare Investors (OHI) and Medical Properties Trust (MPW) caters to the senior housing/assisted living facilities. Given the growing senior population, it makes sense to be somewhat over-exposed to companies that target this market.


Read more...

 

Buffett: Still banking on banks
by Ron Rowland, editor All Star Investor

Wise investors zero in on conflicting data points. Warren Buffett, the wisest investor of all, provided plenty to consider at the Berkshire Hathaway annual meeting. 


Read more...

 

Questcor: 'Exponential demand'
by Dennis Slothower, editor Stealth Stocks

Questcor Pharmaceuticals (QCOR), our latest featured stock of the month, is a biopharmaceutical company whose primary product helps patients with serious, difficult-to-treat medical conditions.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary